Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III
Autor: | Cinzia Galimberti, Savina Mannarino, Roberta Pretese, Rossella Parini, Alessandra Brambilla, Serena Gasperini |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
Variable severity
medicine.medical_specialty congenital hereditary and neonatal diseases and abnormalities business.industry medicine.medical_treatment Cardiomyopathy nutritional and metabolic diseases High fat diet High-protein diet Disease Glycogen storage disease type III medicine.disease medicine.disease_cause Article Endocrinology Cardiac hypertrophy Internal medicine Medicine business Ketogenic diet |
Zdroj: | JIMD Reports ISBN: 9783662445778 |
Popis: | Glycogenosis type III (GSD III) is an autosomal recessive disorder due to amylo-1,6-glucosidase deficiency. This disease causes limit dextrin storage in affected tissues: liver, skeletal muscles, and heart in GSD IIIa and only liver in GSD IIIb. Cardiomyopathy is quite frequent in GSD IIIa with variable severity and progression of manifestations. It is not clear if diet manipulation may interfere with cardiomyopathy's progression. Recent case reports showed improvement of cardiomyopathy following a ketogenic diet.Two siblings (girl and boy), 7- and 5-year-old, both affected with GSD IIIa, developed severe and rapidly worsening left ventricular hypertrophy in the first years of life, while treated with frequent diurnal and nocturnal hyperproteic meals followed by orally administered uncooked cornstarch. Subsequently they were treated with high-fat (60%) and high-protein (25%), low-carbohydrate (15%) diet. After 12 months exertion dyspnea disappeared in the girl and biochemical blood tests, cardiac enzymes, and congestive heart failure markers improved in both (CK 3439→324, 1304→581 U/L; NT-proBNP 2084→206, 782→135 pg/mL, respectively); ultrasound assessment in both patients showed a relevant reduction of the thickness of interventricular septum (30→16, 16→11 mm, respectively) and left ventricle posterior wall (18→7, 13→8 mm, respectively) and an improvement of the outflow obstruction. A diet rich in fats as well as proteins and poor in carbohydrates could be a beneficial therapeutic choice for GSD III with cardiomyopathy. Future research is needed to confirm the beneficial effect of this treatment and to design treatment strategies with the aim to provide alternative source of energy and prevent glycogen accumulation. |
Databáze: | OpenAIRE |
Externí odkaz: |